Gulf Coast TX
Vertex and CRISPR Therapeutics Announce Global exa-cel Regulatory Submissions for Sickle Cell Disease and Beta Thalassemia in 2022
BOSTON & ZUG, Switzerland--(BUSINESS WIRE)--Sep 27, 2022-- |!| Rosenberg
